2020- Present
1. Noormohammadpour P, Hueniken K, Pienkowski M, Huang SH, Yuan B, Grant B, Yao C, Hope A, Tsai J, McPartlin A, Goldstein D, Hosni A, de Almeida JR, Grant RC, Liu G, Li Y. Differential prognostic association of systemic inflammatory biomarkers on survival outcomes in head and neck squamous cell carcinoma patients by human papillomavirus status. Neoplasia. 2025 Aug;66:101178.
2. Dong M, Thakral A, Byrne KS, Bosse Y, Zhou H, Zhang Y, Atkins J, Haycock P, Brown MC, Murison K, Timens W, Sin DD, Kothari J, Gabriel AAG, Zaridze D, Savic M, Lissowska J, Świątkowska B, Janout V, Holcatova I, Mukeria A, Fernandez-Tardon G, Davies MPA, Triplette M, Schabath MB, Andrew AS, Chen C, Taylor F, Field JK, Tardon A, Shete SS, Brennan P, Landi MT, McKay J, Amos CI, Lin X, Christiani DC, Hung RJ, Liu G, Xu W. Genome-wide association study of early-stage non-small cell lung cancer prognosis: a pooled analysis in the International Lung Cancer Consortium. Carcinogenesis. 2025 Aug;46(2):bgaf031.
3. Jimenez Munarriz BE, Khan S, Li Y, Ghazali N, Liu G. Update advances in anaplastic lymphoma kinase-positive non-small cell lung cancer treatment. Cancer. 2025 Mar;131(Suppl 1):e35786.
4. Samir Barghout, Nicholas Meti, Simren Chotai, Christina Kim, Devalben Patel, M. Brown, Katrina Hueniken, Luna Zhan, Stavroula Raptis, Faisal Al-Agha, Christopher Deutschman, Benjamin Grant, Martha Pienkowski, Patrick Moriarty, John de Almeida, David Goldstein, Scott Bratman, Frances Shepherd, Ming-Sound Tsao, Andrew Freedman, Wei Xu, and Geoffrey Liu. Adaptive Universal Principles for Real-world Observational Studies (AUPROS): An approach to designing real-world observational studies for clinical, epidemiologic, and precision oncology research. British Journal of Cancer. 2025 Feb;132(2):139-153.
5. Chan SWS, Zeng J, Young J, Barghout SH, Al-Agha F, Raptis S, Brown MC, Liu G, Juergens R, Jao K: A Poor Prognostic ALK Phenotype: A Review of Molecular Markers of Poor Prognosis in ALK Rearranged Nonsmall Cell Lung Cancer. Clinical lung cancer 2025, 26(1):e22-e32.e22.
6. Lam ACL, Hueniken K, Pienkowski M, Lee JJW, Dong M, Diergaarde B, Olshan AF, Brennan P, Virani S, Saunders D et al: Performance of 8 Smoking Metrics for Modeling Survival in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngology–Head & Neck Surgery 2025.
7. Sabine Schmid; Luna Zhan; Miguel Garcia; Kristen Dietrich; Khaleeq Khan; Maisha Chowdhury; Michael Herman; Devalben Patel; Fatemeh Zaeimi; Natasha B. Leighl; Adrian Sacher; Ronald Feld; Frances A. Shepherd; Laura Donahoe; Marc de Perrot; B.C. John Cho; Geoffrey Liu; Penelope A. Bradbury. Immediate versus deferred systemic therapy in patients with mesothelioma. Clinical Lung Cancer. 2024 Nov;25(7):e277-e285.
8. Thakral A, Lee JJ, Hou T, Hueniken K, Dudding T, Gormley M, Virani S, Olshan A, Diergaarde B, Ness AR et al: Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study. Nat Commun 2024, 15(1):7835.
9. John Lee, Abhinav Thakral, Tianzhichao Hou, Katrina Hueniken, Tom Dudding, Mark Gormley, Shama Virani, Andrew Olshan, Brenda Diergaarde, Andrew Ness, Tim Waterboer, Karl Smith-Byrne, Paul Brennan, D Hayes, Eleanor Sanderson, M. Catherine Brown, Sophie Huang, Scott Bratman, Anna Spreafico, John de Almeida, Joel Davies, Laura Bierut, Gary Macfarlane, Pagona Lagiou, Areti Lagiou, Jerry Polesel, Antonio Agudo, Laia Alemany, Wolfgang Ahrens, Claire Healy, David Conway, Mari Nygård, Cristina Canova, Ivana Holcatova, Lorenzo Richiardi, Ariana Znaor, David Goldstein, Rayjean Hung, Wei Xu, Geoffrey Liu, and Osvaldo Espin-Garcia. Smoking and Alcohol by HPV Status in Head and Neck Cancer A Mendelian Randomization Study. Nature Communications. 2024 Sep;15(1):7835.
10. Schmid S, Garcia M, Zhan L, Cheng S, Khan K, Chowdhury M, Sabouhanian A, Herman J, Walia P, Strom E et al: Outcomes with non-small cell lung cancer and brain-only metastasis. Heliyon 2024, 10(17):e37082.
11. Li Y, Wong M, Zhan L, Corke L, Brown MC, Cheng S, Khan K, Balatnaram K, Chowdhury M, Sabouhanian A, Herman J, Walia P, Strom E, Patel D, García-Pardo M, Schmid S, Eng L, Sacher AG, Leighl N, Bradbury PA, Shepherd FA, Shultz D, Liu G. Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort. Lung Cancer. 2024 Jun;192:107823.
12. Lee JJ, Alamleh S, Zhan LJ, Hueniken K, Mahler MB, Billfalk-Kelly A, Davies J, Brown MC, Spreafico A, Huang SH et al: Clinical Predictors of Cisplatin Chemoradiation-Induced Ototoxicity in HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study. J Otolaryngol Head Neck Surg 2024, 53:19160216241248671.
13. Ghazali N, Feng J, Hueniken K, Khan K, Balaratnam K, Waddell TK, Yasufuku K, Pierre A, Donahoe L, Wakeam E et al: Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations. Ther Adv Med Oncol 2024, 16:17588359241308466.
14. Chan SWS, Zeng J, Young J, Barghout SH, Al-Agha F, Raptis S, Brown MC, Liu G, Juergens R, Jao K: A poor prognostic ALK phenotype: A review of molecular markers of poor prognosis in ALK re-arranged non-small cell lung cancer. Clinical lung cancer 2024.
15. Barghout SH, Zhan LJ, Raptis S, Al-Agha F, Esfahanian N, Popovacki A, Kasymjanova G, Proulx-Rocray F, Chan SWS, Richardson M et al: Treatment patterns and outcomes in KRAS(G12C)-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort study. Lung Cancer 2024, 194:107898.
16. Barghout SH, Meti N, Chotai S, Kim CJH, Patel D, Brown MC, Hueniken K, Zhan LJ, Raptis S, Al-Agha F et al: Adaptive Universal Principles for Real-world Observational Studies (AUPROS): an approach to designing real-world observational studies for clinical, epidemiologic, and precision oncology research. Br J Cancer 2024.
17. Lee JJW, Kunaratnam V, Kim CJH, Pienkowski M, Hueniken K, Sahovaler A, Lam ACL, Davies JC, Brown CM, De Almeida JR et al: Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis. Cancer 2023.
18. Zeuge U, Fares AF, Soriano J, Hueniken K, Bajwa J, Wang W, Schmid S, Rudolph-Naiberg S, Brown MC, Yeung J et al: Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinoma. Esophagus 2023.
19. Schmid S, Cheng S, Chotai S, Garcia M, Zhan L, Hueniken K, Balaratnam K, Khan K, Patel D, Grant B et al: Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer. Clinical lung cancer 2023, 24(1):40-50.
20. Lee JJW, Kunaratnam V, Kim CJH, Pienkowski M, Hueniken K, Sahovaler A, Lam ACL, Davies JC, Brown CM, De Almeida JR et al: Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis. Cancer 2023, 129(6):867-877.
21. Herman M, Lok BH, Gallinger S, Dawson L, Kim R, Cheng D, Paton T, Bucur R, Patel D, Fazelzad R et al: Analysis of prognostic germline polymorphisms in patients with advanced hepatocellular carcinoma. Transl Gastroenterol Hepatol 2023, 8:32
22. Fares AF, Li Y, Jiang M, Brown MC, Lam ACL, Aggarwal R, Schmid S, Leighl NB, Shepherd FA, Wang Z et al: Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. The Lancet Public Health 2023, 8(9):e691-e700.
23. Esfahanian N, Chan SWS, Zhan LJ, Brown MC, Khan K, Lee J, Balaratnam K, Yan E, Parker J, Garcia-Pardo M et al: Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence. Cancer Treatment and Research Communications 2023, 37:100774.
24. García-Pardo M, Chang A, Schmid S, Dong M, Brown MC, Christiani D, Tindel HA, Brennan P, Chen C, Zhang J et al: Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium. Journal of Thoracic Oncology 2023, 18(3):313-323.
25. Weiss J, Pham NA, Pintilie M, Li M, Liu G, Shepherd FA, Tsao MS, Xu W: Optimizing Drug Response Study Design in Patient-Derived Tumor Xenografts. Cancer Inform 2022, 21:11769351221136056.
26. Schmid S, Zhan L, Dietrich K, Khan K, Chowdhury M, Herman M, Patel D, Zaeimi F, Leighl NB, Sacher A et al: Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral Centre. Clinical lung cancer 2022, 23(1):e43-e53.
27. Schmid S, Jiang M, Brown MC, Fares A, Garcia M, Soriano J, Dong M, Thomas S, Kohno T, Leal LF et al: Accounting for EGFR Mutations in Epidemiologic Analyses of Non-Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data. Cancer Epidemiol Biomarkers Prev 2022, 31(3):679-687.
28. Schmid S, Garcia M, Cheng S, Zhan L, Chotai S, Balaratnam K, Khan K, Patel D, Catherine Brown M, Sachdeva R et al: Treatment patterns and outcomes in early-stage ALK-rearranged non-small cell lung cancer. Lung Cancer 2022, 166:58-62.
29. Schmid S, Cheng S, Chotai S, Garcia M, Zhan L, Hueniken K, Balaratnam K, Khan K, Patel D, Grant B et al: Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer. Clinical lung cancer 2022.
30. Ren J, Pang W, Luo Y, Cheng D, Qiu K, Rao Y, Zheng Y, Dong Y, Peng J, Hu Y et al: Impact of Allergic Rhinitis and Asthma on COVID-19 Infection, Hospitalization, and Mortality. The journal of allergy and clinical immunology in practice (Cambridge, MA) 2022, 10(1):124-133.
31. Ren J, Pang W, Hueniken K, Haddad G, Hope A, Huang SH, Spreafico A, Hansen AR, Perez‐Ordonez B, Goldstein DP et al: Longitudinal health utility and symptom‐toxicity trajectories in patients with head and neck cancers. Cancer 2022, 128(3):497-508.
32. Kuehne N, Hueniken K, Xu M, Shakik S, Vedadi A, Pinto D, Brown MC, Bradbury PA, Shepherd FA, Sacher AG et al: Longitudinal Assessment of Health Utility Scores, Symptoms and Toxicities in Patients with Small Cell Lung Cancer Using Real World Data. Clinical lung cancer 2022, 23(2):e154-e164.
33. Haddad G, Hueniken K, Xu MC, Bratman S, de Almeida J, Goldstein D, Huang SH, Hansen A, Hope A, Spreafico A et al: Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancer. Head Neck 2022, 44(10):2181-2196.
34. Garcia-Pardo M, Czarnecka K, Law JH, Salvarrey A, Fernandes R, Fan J, Corke L, Waddell TK, Yasufuku K, Donahoe LL et al: Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy. Therapeutic advances in medical oncology 2022, 14:17588359221126151-17588359221126151.
35. Sung MR, Tomasini P, Le LW, Kamel-Reid S, Tsao M-S, Liu G, Bradbury PA, Shepherd FA, Li JJN, Feld R et al: Effects of Ethnicity on Outcomes of Patients With EGFR Mutation–Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection. JTO clinical and research reports 2022, 3(2):100259-100259.
36. Zazuli Z, de Jong C, Xu W, Vijverberg SJH, Masereeuw R, Patel D, Mirshams M, Khan K, Cheng D, Ordonez-Perez B et al: Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study. Journal of personalized medicine 2021, 11(11):1233.
37. Xu Y, Yang W, Song Y, Cheng D, Cao M, Huang J, Ren J, Lee JW, Hueniken K, Chen Y et al: Association of gastro-oesophageal reflux disease and quality of life in patients with chronic rhinosinusitis. Acta Otorhinolaryngol Ital 2021, 41(5):450-460.
38. Vedadi, A., S. Shakik, M.C. Brown, B.H. Lok, F.A. Shepherd, N.B. Leighl, A. Sacher, P.A. Bradbury, W. Xu, G. Liu, and G.M. O'Kane, The impact of symptoms and comorbidity on health utility scores and health-related quality of life in small cell lung cancer using real world data. Qual Life Res, 2021. 30(2): p. 445-454.
39. Schmid, S., L. Zhan, K. Dietrich, K. Khan, M. Chowdhury, M. Herman, D. Patel, F. Zaeimi, N.B. Leighl, A. Sacher, R. Feld, F.A. Shepherd, L. Donahoe, M. de Perrot, B.C.J. Cho, G. Liu, and P.A. Bradbury, Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral Centre. Clin Lung Cancer, 2021.
40. Lau SCM, Ryan M, Weiss J, Fares AF, Garcia M, Schmid S, Kuang S, Kelly D, Tsao MS, Bradbury PA et al: Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy. JTO Clin Res Rep 2021, 2(12):100251.
41. Lau SCM, Fares AF, Le LW, Mackay KM, Soberano S, Chan SW, Smith E, Ryan M, Tsao MS, Bradbury PA, Pal P, Shepherd FA, Liu G, Leighl NB, Sacher AG. Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint Inhibitors. Clinical lung cancer 2021; 22(4): 253-9.
42. Khan, M.N., K. Hueniken, M. Manojlovic-Kolarski, L. Eng, M. Mirshams, K. Khan, C. Simpson, M. Au, G. Liu, W. Xu, C.J. Longo, D.P. Goldstein, J. Ringash, R. Martino, A.R. Hansen, and J.R. de Almeida, Out-of-pocket costs associated with head and neck cancer treatment. Cancer Rep (Hoboken), 2021: p. e1528.
43. Jiang, M., A.F. Fares, D. Shepshelovich, P. Yang, D. Christiani, J. Zhang, K. Shiraishi, B.M. Ryan, C. Chen, A.G. Schwartz, A. Tardon, S. Shete, M.B. Schabath, M.D. Teare, L. Le Marchand, Z.-F. Zhang, J.K. Field, H. Brenner, N. Diao, J. Xie, T. Kohno, C.C. Harris, A.S. Wenzlaff, G. Fernandez-Tardon, Y. Ye, F. Taylor, L.R. Wilkens, M. Davies, Y. Liu, M.J. Barnett, G.E. Goodman, H. Morgenstern, B. Holleczek, S. Thomas, M.C. Brown, R.J. Hung, W. Xu, and G. Liu, The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients. Lung Cancer, 2021. 152: p. 58-65.
44. Herman, M., Z. Liu, F.A. Shepherd, N. Leighl, G. Liu, and P.A. Bradbury, The effect of prior cancer on non-small cell lung cancer trial eligibility. Cancer Med, 2021. 10(14): p. 4814-4822.
45. de Oliveira Faria S, Hurwitz G, Kim J, Liberty J, Orchard K, Liu G, Barbera L, Howell D. Identifying Patient-Reported Outcome Measures (PROMs) for Routine Surveillance of Physical and Emotional Symptoms in Head and Neck Cancer Populations: A Systematic Review. Journal of clinical medicine 2021; 10(18).
46. Chan, S.W.S., E. Smith, R. Aggarwal, K. Balaratnam, R. Chen, K. Hueniken, R. Fazelzad, J. Weiss, S. Jiang, F.A. Shepherd, P.A. Bradbury, A.G. Sacher, N.B. Leighl, W. Xu, M.C. Brown, L. Eng, and G. Liu, Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis. Clin Lung Cancer, 2021.
47. Bender, J.L., K. Hueniken, L. Eng, M.C. Brown, S. Kassirian, I. Geist, K. Balaratnam, M. Liang, C.B. Paulo, A. Geist, P. Rao, A. Magony, E.C. Smith, W. Xu, G. Liu, and A.A. Gupta, Internet and social media use in cancer patients: association with distress and perceived benefits and limitations. Supportive Care in Cancer, 2021.
48. Xu, Y., Y. Zheng, M. Cao, W. Yang, J. Ren, Y. Song, D. Cheng, J. Wang, L. Huang, W. Xu, Y. Zhao, and G. Liu, Association of Single-Nucleotide Polymorphisms With Chronic Rhinosinusitis in a Southwestern Han Chinese Population: A Replication Study. Am J Rhinol Allergy, 2020. 34(3): p. 352-360.
49. Schmid, S., E.L. Stewart, S.N. Martins-Filho, M. Cabanero, A. Wang, H. Bao, X. Wu, D. Patel, Z. Chen, J.H. Law, P.A. Bradbury, F.A. Shepherd, N. Leighl, M.S. Tsao, T. Pugh, S.V. Bratman, A. Sacher, and G. Liu, Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib. Clin Lung Cancer, 2020. 21(5): p. e488-e492.
50. Ren, J., W. Xu, J. Su, X. Ren, D. Cheng, Z. Chen, N. Bender, M. Mirshams, S. Habbous, J.R. de Almeida, B. Perez-Ordonez, D.P. Goldstein, J.R. Wang, S.V. Bratman, S.H. Huang, R. Jang, Y. Zhao, T. Waterboer, R.J. Hung, and G. Liu, Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable. Int J Cancer, 2020. 146(8): p. 2166-2174.
51. Ren, J., X. Jing, J. Wang, X. Ren, Y. Xu, Q. Yang, L. Ma, Y. Sun, W. Xu, N. Yang, J. Zou, Y. Zheng, M. Chen, W. Gan, T. Xiang, J. An, R. Liu, C. Lv, K. Lin, X. Zheng, F. Lou, Y. Rao, H. Yang, K. Liu, G. Liu, T. Lu, X. Zheng, and Y. Zhao, Automatic Recognition of Laryngoscopic Images Using a Deep-Learning Technique. Laryngoscope, 2020. 130(11): p. E686-e693.
52. Lee, M.J., K. Hueniken, N. Kuehne, L. Lu, S.X. Jiang, B. Id Said, A. McCartney, Y. Gao, M. Liang, T. Obuobi, H. Sorotsky, L. Eng, M.C. Brown, W. Xu, and G. Liu, Cancer Patient-Reported Preferences and Knowledge for Liquid Biopsies and Blood Biomarkers at a Comprehensive Cancer Center. Cancer Manag Res, 2020. 12: p. 1163-1173.
53. Kuehne N, Hueniken K, Xu W, Shakik S, Vedadi A, Pinto D, Brown M, Bradbury P, Shepherd F, Sacher A et al: Predictors of and longitudinal assessment of health utility scores in patients with small cell lung cancer using real-world data. In: Journal of Clinical Oncology. vol. 38; 2020: e19306-e19306.
54. Haddad G, Schouwenburg S, Altesha A, Xu W, Liu G: Using breath analysis as a screening tool to detect gastric cancer: a systematic review. Journal of breath research 2020, 15(1).
55. Eng, L., J. Bender, K. Hueniken, S. Kassirian, L. Mitchell, R. Aggarwal, C. Paulo, E.C. Smith, I. Geist, K. Balaratnam, A. Magony, M. Liang, D. Yang, J.M. Jones, M.C. Brown, W. Xu, S.C. Grover, S.M.H. Alibhai, G. Liu, and A.A. Gupta, Age differences in patterns and confidence of using internet and social media for cancer-care among cancer survivors. Journal of Geriatric Oncology, 2020. 11(6): p. 1011-1019.
56. Eng, L., D. Alton, Y. Song, J. Su, Q. Zhang, J. Che, D. Farzanfar, R. Mohan, O. Krys, K. Mattina, C. Harper, S. Liu, T. Yoannidis, R. Milne, N. Abdelmutti, M.C. Brown, A. Vennettilli, A.J. Hope, D. Howell, J.M. Jones, P. Selby, W.K. Evans, W. Xu, D.P. Goldstein, M.E. Giuliani, and G. Liu, Awareness of the Harms of Continued Smoking Among Cancer Survivors. Support Care Cancer, 2020. 28(7): p. 3409-3419.
57. Aggarwal, R., K. Hueniken, L. Eng, S. Kassirian, I. Geist, K. Balaratnam, M. Liang, C.B. Paulo, A. Geist, P. Rao, L. Mitchell, A. Magony, J.M. Jones, S.C. Grover, M.C. Brown, J. Bender, W. Xu, G. Liu, and A.A. Gupta, Health-related social media use and preferences of adolescent and young adult cancer patients for virtual programming. Supportive Care in Cancer, 2020. 28(10): p. 4789-4801.
58. Zazuli, Z., L.S. Otten, B.I. Drögemöller, M. Medeiros, J.G. Monzon, G.E.B. Wright, C.K. Kollmannsberger, P.L. Bedard, Z. Chen, K.A. Gelmon, N. McGoldrick, A. Kitchlu, S.J.H. Vijverberg, R. Masereeuw, C.J.D. Ross, G. Liu, B.C. Carleton, and A.H. Maitland-van der Zee, Outcome Definition Influences the Relationship Between Genetic Polymorphisms of. Genes (Basel), 2019. 10(5).
59. Tomasini, P., C. Mascaux, K. Jao, C. Labbe, S. Kamel-Reid, T. Stockley, D.M. Hwang, N.B. Leighl, G. Liu, P.A. Bradbury, M. Pintilie, M.S. Tsao, and F.A. Shepherd, Effect of Coexisting KRAS and TP53 Mutations in Patients Treated With Chemotherapy for Non-small-cell Lung Cancer. Clin Lung Cancer, 2019. 20(3): p. e338-e345.
60. Soldera, S.V., S. Shakik, H. Naik, M. Moskovitz, J. Chen, N. Mittmann, W. Xu, A. Hope, A. Bezjak, A. Parajian, S. Keshavjee, and G. Liu, Favourable health-related quality of life reported in survivors of thymic malignancies. Eur J Cardiothorac Surg, 2019. 55(2): p. 292-299.
61. Shepshelovich, D., W. Xu, L. Lu, A. Fares, P. Yang, D. Christiani, J. Zhang, K. Shiraishi, B.M. Ryan, C. Chen, A.G. Schwartz, A. Tardon, X. Wu, M.B. Schabath, M.D. Teare, L. Le Marchand, Z.F. Zhang, J.K. Field, H. Brenner, N. Daio, J. Xie, T. Kohno, C.C. Harris, A.S. Wenzlaff, G. Fernandez-Tardon, Y. Ye, F. Taylor, L.R. Wilkens, M. Davies, Y. Liu, M.J. Barnett, G.E. Goodman, H. Morgenstern, B. Holleczek, M.C. Brown, G. Liu, and R. Hung, Body mass index (BMI), BMI change, and overall survival in small cell and non-small cell lung cancer patients: a pooled analysis of the International Lung Cancer Consortium. J Thorac Oncol, 2019.
62. Ren, J., W. Yang, S. Su, X. Ren, R. Fazelzad, Z. Yu, T. Albert, D. Goldstein, J. de Almeida, A. Hansen, R. Jang, S. Bratman, A. Hope, R. Chen, J. Wang, Y. Xu, D. Cheng, W. Xu, and G. Liu, Human Papillomavirus and p16 Immunostaining, Prevalence and Prognosis of Squamous Carcinoma of Unknown Primary in the Head and Neck Region. International Journal of Cancer, 2019. 145.
63. O'Kane, G.M., J. Su, B.C. Tse, V. Tam, T. Tse, L. Lu, M. Borean, E. Tam, C. Labbe, H. Naik, N. Mittmann, M.K. Doherty, P.A. Bradbury, N.B. Leighl, F.A. Shepherd, N.M. Richard, K. Edelstein, D. Shultz, M.C. Brown, W. Xu, D. Howell, and G. Liu, The Impact of Brain Metastases and Associated Neurocognitive Aspects on Health Utility Scores in EGFR Mutated and ALK Rearranged NSCLC: A Real World Evidence Analysis. Oncologist, 2019.
64. O'Kane, G.M., G. Liu, T.L. Stockley, M. Shabir, T. Zhang, J.H. Law, L.W. Le, A. Sacher, F.A. Shepherd, P.A. Bradbury, and N.B. Leighl, The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance. Lung Cancer, 2019. 131: p. 86-89.
65. Liu, S.Y., L. Lu, D. Pringle, M. Mahler, C. Niu, R. Charow, K. Tiessen, C. Lam, O. Halytskyy, H. Naik, H. Hon, M. Irwin, V. Pat, C. Gonos, C.W.T. Chan, J. Villeneuve, R.M. Shani, M. Chaudhry, M.C. Brown, P. Selby, D. Howell, W. Xu, S.M.H. Alibhai, J.M. Jones, G. Liu, and L. Eng, Impact of immigration status on health behaviors and perceptions in cancer survivors. Cancer Med, 2019. 8(5): p. 2623-2635.
66Lee, M.J., N. Kuehne, K. Hueniken, S. Liang, S. Rai, H. Sorotsky, M. Herman, D. Shepshelovich, J. Bruce, M. Liang, D. Patel, D. Cheng, Z. Chen, L. Eng, M.C. Brown, J. Cho, N.B. Leighl, M. de Perrot, D. Reisman, W. Xu, P.A. Bradbury, and G. Liu, Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis. Mol Carcinog, 2019.
67. Kachuri, L., O. Saarela, S.E. Bojesen, G. Davey Smith, G. Liu, M.T. Landi, N.E. Caporaso, D.C. Christiani, M. Johansson, S. Panico, K. Overvad, A. Trichopoulou, P. Vineis, G. Scelo, D. Zaridze, X. Wu, D. Albanes, B. Diergaarde, P. Lagiou, G.J. Macfarlane, M.C. Aldrich, A. Tardón, G. Rennert, A.F. Olshan, M.C. Weissler, C. Chen, G.E. Goodman, J.A. Doherty, A.R. Ness, H. Bickeböller, H.E. Wichmann, A. Risch, J.K. Field, M.D. Teare, L.A. Kiemeney, E. van der Heijden, J.C. Carroll, A. Haugen, S. Zienolddiny, V. Skaug, V. Wünsch-Filho, E.H. Tajara, R. Ayoub Moysés, F. Daumas Nunes, S. Lam, J. Eluf-Neto, M. Lacko, W.H.M. Peters, L. Le Marchand, E.J. Duell, A.S. Andrew, S. Franceschi, M.B. Schabath, J. Manjer, S. Arnold, P. Lazarus, A. Mukeriya, B. Swiatkowska, V. Janout, I. Holcatova, J. Stojsic, D. Mates, J. Lissowska, S. Boccia, C. Lesseur, X. Zong, J.D. McKay, P. Brennan, C.I. Amos, and R.J. Hung, Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers. Int J Epidemiol, 2019. 48(3): p. 751-766.
68. Kachuri, L., J. Helby, S.E. Bojesen, D.C. Christiani, L. Su, X. Wu, A. Tardon, G. Fernandez-Tardon, J.K. Field, M.P. Davies, C. Chen, G.E. Goodman, F.A. Shepherd, N.B. Leighl, M.S. Tsao, Y. Brhane, M.C. Brown, K. Boyd, D. Shepshelovich, L. Sun, C.I. Amos, G. Liu, and R.J. Hung, Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer. Cancer Epidemiol Biomarkers Prev, 2019. 28(7): p. 1228-1237.
69. Jiang, S.X., R.N. Walton, K. Hueniken, J. Baek, A. McCartney, C. Labbé, E. Smith, S.W.S. Chan, R. Chen, C. Brown, D. Patel, M. Liang, L. Eng, A. Sacher, P. Bradbury, N.B. Leighl, F.A. Shepherd, W. Xu, G. Liu, M. Hurry, and G.M. O'Kane, Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancer. Cancer Medicine, 2019. 8(18): p. 7542-7555.
70. Hall, E., E. Tam, M. Liang, Q. Zhang, L. Liu, L. Wong, S. Sarabia, S. Yeung, G. Gill, L. Eng, A. Perez-Cosio, M.C. Brown, W. Xu, M. Li, N. Mittmann, J. Jones, D. Howell, and G. Liu, Development and prospective evaluation of CAPLET, a cancer ambulatory patient physical function longitudinal evaluation tool for routine clinical practice. Support Care Cancer, 2019. 27(2): p. 521-530.
71. Giuliani, M.E., G. Liu, W. Xu, M. Dirlea, P. Selby, J. Papadakos, N. Abdelmutti, D. Yang, L. Eng, D.P. Goldstein, and J.M. Jones, Implementation of a Novel Electronic Patient-Directed Smoking Cessation Platform for Cancer Patients: Interrupted Time Series Analysis. Journal of medical Internet research, 2019. 21(4): p. e11735-e11735.
72. Ezeife, D.A., B.J. Morganstein, S. Lau, J.H. Law, L.W. Le, J. Bredle, D. Cella, M.K. Doherty, P. Bradbury, G. Liu, A. Sacher, F.A. Shepherd, and N.B. Leighl, Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System. Clin Lung Cancer, 2019. 20(4): p. 231-236.
73. Eng, L., D. Pringle, J. Su, O. Espin-Garcia, C. Niu, M. Mahler, O. Halytskyy, R. Charow, C. Lam, R.M. Shani, J. Villeneuve, K. Tiessen, A. Dobriyal, A. Zarrin, A. Vennettilli, M.C. Brown, S.M.H. Alibhai, D. Howell, J.M. Jones, P. Selby, W. Xu, and G. Liu, Patterns, perceptions and their association with changes in alcohol consumption in cancer survivors. Eur J Cancer Care (Engl), 2019. 28(1): p. e12933.
74. Albaba, H., T.A. Barnes, Z. Veitch, M.C. Brown, S. Shakik, S. Su, H. Naik, T. Wang, M. Liang, A. Perez-Cosio, L. Eng, N. Mittmann, W. Xu, D. Howell, and G. Liu, Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience. Oncologist, 2019. 24(11): p. e1219-e1227.
75. Aggarwal, R., A.C.L. Lam, M. McGregor, R. Menezes, K. Hueniken, H. Tateishi, G.M. O'Kane, M.S. Tsao, F.A. Shepherd, W. Xu, M. McInnis, H. Schmidt, G. Liu, and J. Kavanagh, Outcomes of Long-term Interval Rescreening With Low-Dose Computed Tomography for Lung Cancer in Different Risk Cohorts. J Thorac Oncol, 2019. 14(6): p. 1003-1011.
76. Zazuli, Z., S. Vijverberg, E. Slob, G. Liu, B. Carleton, J. Veltman, P. Baas, R. Masereeuw, and A.-H. Maitland-van der Zee, Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review. Frontiers in pharmacology, 2018. 9: p. 1111-1111.
77. Teichman, J., L. Dodbiba, H. Thai, A. Fleet, T. Morey, L. Liu, M. McGregor, D. Cheng, Z. Chen, G. Darling, Y. Brhane, Y. Song, O. Espin-Garcia, W. Xu, H. Girgis, J. Schwock, H. MacKay, R. Bristow, L. Ailles, and G. Liu, Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma. PLoS One, 2018. 13(5): p. e0194809.
78. Shepshelovich, D., A.R. Townsend, O. Espin-Garcia, L. Latifovic, C.J. O'Callaghan, D.J. Jonker, D. Tu, E. Chen, E. Morgen, T.J. Price, J. Shapiro, L.L. Siu, M. Kubo, A. Dobrovic, M.J. Ratain, W. Xu, T. Mushiroda, and G. Liu, Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer. Cancer Med, 2018. 7(11): p. 5478-5487.
79. Moradian, S., M.K. Krzyzanowska, R. Maguire, P.P. Morita, V. Kukreti, J. Avery, G. Liu, J. Cafazzo, and D. Howell, Usability Evaluation of a Mobile Phone-Based System for Remote Monitoring and Management of Chemotherapy-Related Side Effects in Cancer Patients: Mixed-Methods Study. JMIR Cancer, 2018. 4(2): p. e10932.
80. Korpanty, G.J., S. Kamel-Reid, M. Pintilie, D.M. Hwang, A. Zer, G. Liu, N.B. Leighl, R. Feld, L.L. Siu, P.L. Bedard, M.-S. Tsao, and F.A. Shepherd, Lung cancer in never smokers from the Princess Margaret Cancer Centre. Oncotarget, 2018. 9(32): p. 22559-22570.
81. Herman, M., M.T. Warkentin, D. Shepshelovich, L. Latifovic, R. Hung, and G. Liu, Heritable Germline Variation and Lung Cancer Susceptibility: One Size Does not Fit All. J Thorac Oncol, 2018. 13(5): p. 601-602.
82. Eng, L., D. Pringle, J. Su, X. Shen, M. Mahler, C. Niu, R. Charow, K. Tiessen, C. Lam, O. Halytskyy, H. Naik, H. Hon, M. Irwin, V. Pat, C. Gonos, C. Chan, J. Villeneuve, L. Harland, R.M. Shani, M.C. Brown, P. Selby, D. Howell, W. Xu, G. Liu, S.M.H. Alibhai, and J.M. Jones, Patterns, perceptions, and perceived barriers to physical activity in adult cancer survivors. Support Care Cancer, 2018. 26(11): p. 3755-3763.
83. Doherty, M.K., Y. Leung, J. Su, H. Naik, D. Patel, L. Eng, Q.Q. Kong, F. Mohsin, M.C. Brown, O. Espin-Garcia, A. Vennettilli, D.J. Renouf, O.O. Faluyi, J.J. Knox, H. MacKay, R. Wong, D. Howell, N. Mittmann, G.E. Darling, D. Cella, W. Xu, and G. Liu, Health utility scores from EQ-5D and health-related quality of life in patients with esophageal cancer: a real-world cross-sectional study. Dis Esophagus, 2018. 31(12).
84. Borean, M., K. Shani, M.C. Brown, J. Chen, M. Liang, J. Karkada, S. Kooner, M.K. Doherty, G.M. O'Kane, R. Jang, E. Elimova, R.K. Wong, G.E. Darling, W. Xu, D. Howell, and G. Liu, Development and evaluation of screening dysphagia tools for observational studies and routine care in cancer patients. Health Sci Rep, 2018. 1(7): p. e48.
85. Alton, D., L. Eng, L. Lu, Y. Song, J. Su, D. Farzanfar, R. Mohan, O. Krys, K. Mattina, C. Harper, S. Liu, T. Yoannidis, R. Milne, M.C. Brown, A. Vennettilli, A.J. Hope, D. Howell, J.M. Jones, P. Selby, W. Xu, D.P. Goldstein, G. Liu, and M.E. Giuliani, Perceptions of Continued Smoking and Smoking Cessation Among Patients With Cancer. J Oncol Pract, 2018. 14(5): p. e269-e279.
86. Spreafico, A., L. Coate, R. Zhai, W. Xu, Z.F. Chen, Z. Chen, D. Patel, B. Tse, M.C. Brown, R.S. Heist, L. Dodbiba, J. Teichman, M. Kulke, L. Su, L. Eng, J. Knox, R. Wong, G.E. Darling, D.C. Christiani, and G. Liu, Early adulthood body mass index, cumulative smoking, and esophageal adenocarcinoma survival. Cancer Epidemiol, 2017. 47: p. 28-34.
87. O'Kane, G.M., P.A. Bradbury, R. Feld, N.B. Leighl, G. Liu, K.M. Pisters, S. Kamel-Reid, M.S. Tsao, and F.A. Shepherd, Uncommon EGFR mutations in advanced non-small cell lung cancer. Lung Cancer, 2017. 109: p. 137-144.
88. Naik, H., D. Howell, S. Su, X. Qiu, M.C. Brown, A. Vennettilli, M. Irwin, V. Pat, H. Solomon, T. Wang, H. Hon, L. Eng, M. Mahler, H. Thai, V. Ho, W. Xu, S.J. Seung, N. Mittmann, and G. Liu, EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre. Patient, 2017. 10(1): p. 105-115.
89. Liu, G., S. Cuffe, S. Liang, A.K. Azad, L. Cheng, Y. Brhane, X. Qiu, D.W. Cescon, J. Bruce, Z. Chen, D. Cheng, D. Patel, B.C. Tse, S.A. Laurie, G. Goss, N.B. Leighl, R. Hung, P.A. Bradbury, L. Seymour, F.A. Shepherd, M.S. Tsao, B.E. Chen, W. Xu, and D.N. Reisman, BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial. Clin Cancer Res, 2017. 23(10): p. 2460-2470.
90. Lam, C., W.F. Liu, R.D. Bel, K. Chan, L. Miller, M.C. Brown, Z. Chen, D. Cheng, D. Patel, W. Xu, G.E. Darling, and G. Liu, Polymorphisms of the FOXF1 and MHC locus genes in individuals undergoing esophageal acid reflux assessments. Dis Esophagus, 2017. 30(2): p. 1-7.
91. Labbe, C., Y. Leung, J.G. Silva Lemes, E. Stewart, C. Brown, A.P. Cosio, M. Doherty, G.M. O'Kane, D. Patel, N. Cheng, M. Liang, G. Gill, A. Rett, H. Naik, L. Eng, N. Mittmann, N.B. Leighl, P.A. Bradbury, F.A. Shepherd, W. Xu, G. Liu, and D. Howell, Real-World EQ5D Health Utility Scores for Patients With Metastatic Lung Cancer by Molecular Alteration and Response to Therapy. Clin Lung Cancer, 2017. 18(4): p. 388-395.e4.
92. Labbé, C., M. Cabanero, G.J. Korpanty, P. Tomasini, M.K. Doherty, C. Mascaux, K. Jao, B. Pitcher, R. Wang, M. Pintilie, N.B. Leighl, R. Feld, G. Liu, P.A. Bradbury, S. Kamel-Reid, M.S. Tsao, and F.A. Shepherd, Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC). Lung Cancer, 2017. 111: p. 23-29.
93. Korpanty, G.J., L. Eng, X. Qiu, O.O. Faluyi, D.J. Renouf, D. Cheng, D. Patel, Z. Chen, B.C. Tse, J.J. Knox, L. Dodbiba, J. Teichman, A.K. Azad, R. Wong, G. Darling, D. Reisman, S. Cuffe, G. Liu, and W. Xu, Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome. Oncotarget, 2017. 8(17): p. 28093-28100.
94. Habbous, S., K.P. Chu, H. Lau, M. Schorr, M. Belayneh, M.N. Ha, S. Murray, B. O'Sullivan, S.H. Huang, S. Snow, M. Parliament, D. Hao, W.Y. Cheung, W. Xu, and G. Liu, Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation. CMAJ, 2017. 189(32): p. E1030-E1040.
95. Gama, R.R., Y. Song, Q. Zhang, M.C. Brown, J. Wang, S. Habbous, L. Tong, S.H. Huang, B. O'Sullivan, J. Waldron, W. Xu, D. Goldstein, and G. Liu, Body mass index and prognosis in patients with head and neck cancer. Head Neck, 2017. 39(6): p. 1226-1233.
96. Faluyi, O.O., L. Eng, X. Qiu, J. Che, Q. Zhang, D. Cheng, N. Ying, A. Tse, Q. Kuang, L. Dodbiba, D.J. Renouf, S. Marsh, S. Savas, H.J. Mackay, J.J. Knox, G.E. Darling, R.K. Wong, W. Xu, A.K. Azad, and G. Liu, Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival. Cancer Med, 2017. 6(2): p. 361-373.
97. Doherty, M.K., G.J. Korpanty, P. Tomasini, M. Alizadeh, K. Jao, C. Labbé, C.M. Mascaux, P. Martin, S. Kamel-Reid, M.S. Tsao, M. Pintilie, G. Liu, P.A. Bradbury, R. Feld, N.B. Leighl, C. Chung, and F.A. Shepherd, Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer. Radiother Oncol, 2017. 123(2): p. 195-202.
98. Wang, J.R., S. Habbous, O. Espin-Garcia, D. Chen, S.H. Huang, C. Simpson, W. Xu, F.F. Liu, D.H. Brown, R.W. Gilbert, P.J. Gullane, J.C. Irish, D.P. Goldstein, and G. Liu, Comorbidity and performance status as independent prognostic factors in patients with head and neck squamous cell carcinoma. Head Neck, 2016. 38(5): p. 736-42.
99. Segedi, M., L.N. Anderson, O. Espin-Garcia, A. Borgida, T. Bianco, D. Cheng, Z. Chen, D. Patel, M.C. Brown, W. Xu, D. Reisman, S. Gallinger, M. Cotterchio, R. Hung, G. Liu, and S.P. Cleary, BRM polymorphisms, pancreatic cancer risk and survival. Int J Cancer, 2016. 139(11): p. 2474-81.
100. Naik, H., X. Qiu, M.C. Brown, M. Mahler, H. Hon, K. Tiessen, H. Thai, V. Ho, C. Gonos, R. Charow, V. Pat, M. Irwin, L. Herzog, A. Ho, W. Xu, D. Howell, S.J. Seung, G. Liu, and N. Mittmann, Cancer Patients? Willingness to Routinely Complete the EQ-5D Instrument at Clinic Visits. J Popul Ther Clin Pharmacol, 2016. 23(3): p. e196-e204.
101. Naik, H., X. Qiu, M.C. Brown, L. Eng, D. Pringle, M. Mahler, H. Hon, K. Tiessen, H. Thai, V. Ho, C. Gonos, R. Charow, V. Pat, M. Irwin, L. Herzog, A. Ho, W. Xu, J.M. Jones, D. Howell, and G. Liu, Socioeconomic status and lifestyle behaviours in cancer survivors: smoking and physical activity. Curr Oncol, 2016. 23(6): p. e546-e555.
102. Martin, P., E. Stewart, N.A. Pham, C. Mascaux, D. Panchal, M. Li, L. Kim, S. Sakashita, D. Wang, J. Sykes, T. Friess, F.A. Shepherd, G. Liu, and M.S. Tsao, Cetuximab Inhibits T790M-Mediated Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Lung Adenocarcinoma Patient-Derived Xenograft Mouse Model. Clin Lung Cancer, 2016. 17(5): p. 375-383.e2.
103. Martin, P., M.C. Brown, O. Espin-Garcia, S. Cuffe, D. Pringle, M. Mahler, J. Villeneuve, C. Niu, R. Charow, C. Lam, R.M. Shani, H. Hon, M. Otsuka, W. Xu, S. Alibhai, J. Jenkinson, and G. Liu, Patient preference: a comparison of electronic patient-completed questionnaires with paper among cancer patients. Eur J Cancer Care (Engl), 2016. 25(2): p. 334-41.
104. Leung, Y.W., C. Brown, A.P. Cosio, A. Dobriyal, N. Malik, V. Pat, M. Irwin, P. Tomasini, G. Liu, and D. Howell, Feasibility and diagnostic accuracy of the Patient-Reported Outcomes Measurement Information System (PROMIS) item banks for routine surveillance of sleep and fatigue problems in ambulatory cancer care. Cancer, 2016. 122(18): p. 2906-17.
105. Cuffe, S., A.K. Azad, X. Qiu, Y. Brhane, Q. Kuang, S. Marsh, S. Savas, Z. Chen, D. Cheng, N.B. Leighl, G. Goss, S.A. Laurie, L. Seymour, P.A. Bradbury, F.A. Shepherd, M.S. Tsao, B.E. Chen, W. Xu, and G. Liu, ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients. Cancer Epidemiol, 2016. 41: p. 50-6.
106. Stewart, E.L., S.Z. Tan, G. Liu, and M.S. Tsao, Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review. Transl Lung Cancer Res, 2015. 4(1): p. 67-81.
107. Stewart, E.L., C. Mascaux, N.A. Pham, S. Sakashita, J. Sykes, L. Kim, N. Yanagawa, G. Allo, K. Ishizawa, D. Wang, C.Q. Zhu, M. Li, C. Ng, N. Liu, M. Pintilie, P. Martin, T. John, I. Jurisica, N.B. Leighl, B.G. Neel, T.K. Waddell, F.A. Shepherd, G. Liu, and M.S. Tsao, Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma. J Clin Oncol, 2015. 33(22): p. 2472-80.
108. Niu, C., L. Eng, X. Qiu, X. Shen, O. Espin-Garcia, Y. Song, D. Pringle, M. Mahler, O. Halytskyy, R. Charow, C. Lam, R.M. Shani, J. Villeneuve, K. Tiessen, M.C. Brown, P. Selby, D. Howell, J.M. Jones, W. Xu, G. Liu, and S.M. Alibhai, Lifestyle Behaviors in Elderly Cancer Survivors: A Comparison With Middle-Age Cancer Survivors. J Oncol Pract, 2015. 11(4): p. e450-9.
109. Moradian, S. and D. Howell, Prevention and management of chemotherapy-induced nausea and vomiting. Int J Palliat Nurs, 2015. 21(5): p. 216, 218-24.
110. Huang, S.H., J.N. Waldron, M. Milosevic, X. Shen, J. Ringash, J. Su, L. Tong, B. Perez-Ordonez, I. Weinreb, A.J. Bayley, J. Kim, A. Hope, B.C. Cho, M. Giuliani, A. Razak, D. Goldstein, W. Shi, F.F. Liu, W. Xu, and B. O'Sullivan, Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status. Cancer, 2015. 121(4): p. 545-55.
111. Graham, D.M., W. Isaranuwatchai, S. Habbous, C. de Oliveira, G. Liu, L.L. Siu, and J.S. Hoch, A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer. Cancer, 2015. 121(11): p. 1785-92.
112. Eng, L., X. Qiu, J. Su, D. Pringle, C. Niu, M. Mahler, R. Charow, J. Villeneuve, O. Halytskyy, C. Lam, K. Tiessen, M.C. Brown, D. Howell, M.E. Giuliani, J.M. Jones, S.M. Alibhai, D.P. Goldstein, W. Xu, P. Selby, and G. Liu, The role of second-hand smoke exposure on smoking cessation in non-tobacco-related cancers. Cancer, 2015. 121(15): p. 2655-63.
113. Eng, L., A.K. Azad, X. Qiu, Q.Q. Kong, D. Cheng, N. Ying, A. Tse, Q. Kuang, L. Dodbiba, D.J. Renouf, S. Marsh, S. Savas, H.J. Mackay, J.J. Knox, G.E. Darling, R.K. Wong, W. Xu, G. Liu, and O.O. Faluyi, Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome. Carcinogenesis, 2015. 36(9): p. 956-62.
114. Dodbiba, L., J. Teichman, A. Fleet, H. Thai, M.H. Starmans, R. Navab, Z. Chen, H. Girgis, L. Eng, O. Espin-Garcia, X. Shen, B. Bandarchi, J. Schwock, M.S. Tsao, H. El-Zimaity, S.D. Der, W. Xu, R.G. Bristow, G.E. Darling, P.C. Boutros, L.E. Ailles, and G. Liu, Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers. PLoS One, 2015. 10(3): p. e0121872.
115. Cuffe, S., H. Hon, K. Tobros, O. Espin-Garcia, Y. Brhane, L. Harland, E. Fadhel, L. Eng, A. LaDelfa, J. Waldron, L.L. Siu, B.E. Chen, W. Xu, C. Simmons, Z. Kassam, A. Montenegro, W.R. Parulekar, and G. Liu, Cancer patients' acceptability of incorporating an epidemiology questionnaire within a clinical trial. Clin Trials, 2015. 12(3): p. 237-45.
116. Wong, K.M., X. Qiu, D. Cheng, A.K. Azad, S. Habbous, P. Palepu, M. Mirshams, D. Patel, Z. Chen, H. Roberts, J. Knox, S. Marquez, R. Wong, G. Darling, J. Waldron, D. Goldstein, N. Leighl, F.A. Shepherd, M. Tsao, S. Der, D. Reisman, and G. Liu, Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers. Cancer Med, 2014. 3(2): p. 426-33.
117. Shen, X., O. Espin-Garcia, X. Qiu, Y. Brhane, G. Liu, and W. Xu, Haplotype approach for association analysis on hypertension. BMC Proc, 2014. 8(Suppl 1 Genetic Analysis Workshop 18Vanessa Olmo): p. S57.
118. Qiu, X., X. Shen, O. Espin-Garcia, A.K. Azad, G. Liu, and W. Xu, Genetic association analysis using weighted false discovery rate approach on Genetic Analysis Workshop 18 data. BMC Proc, 2014. 8(Suppl 1 Genetic Analysis Workshop 18Vanessa Olmo): p. S76.
119. Habbous, S., V. Pang, W. Xu, E. Amir, and G. Liu, Human papillomavirus and host genetic polymorphisms in carcinogenesis: a systematic review and meta-analysis. J Clin Virol, 2014. 61(2): p. 220-9.
120. Habbous, S., L.T. Harland, A. La Delfa, E. Fadhel, W. Xu, F.F. Liu, D. Goldstein, J. Waldron, S.H. Huang, B. O'Sullivan, and G. Liu, Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status. Head Neck, 2014. 36(6): p. 802-10.
121. Espin-Garcia, O., X. Shen, X. Qiu, Y. Brhane, G. Liu, and W. Xu, Genetic association analysis for common variants in the Genetic Analysis Workshop 18 data: a Dirichlet regression approach. BMC Proc, 2014. 8(Suppl 1 Genetic Analysis Workshop 18Vanessa Olmo): p. S70.
122. Eng, L., J. Su, X. Qiu, P.R. Palepu, H. Hon, E. Fadhel, L. Harland, A. La Delfa, S. Habbous, A. Kashigar, S. Cuffe, F.A. Shepherd, N.B. Leighl, A.F. Pierre, P. Selby, D.P. Goldstein, W. Xu, and G. Liu, Second-hand smoke as a predictor of smoking cessation among lung cancer survivors. J Clin Oncol, 2014. 32(6): p. 564-70.
123. Cuffe, S., H. Hon, X. Qiu, K. Tobros, C.K. Wong, B. De Souza, G. McFarlane, S. Masroor, A.K. Azad, E. Hasani, N. Rozanec, N. Leighl, S. Alibhai, W. Xu, A.M. Issa, and G. Liu, Cancer patients acceptance, understanding, and willingness-to-pay for pharmacogenomic testing. Pharmacogenet Genomics, 2014. 24(7): p. 348-55.
124. Bergman, H., T. Walton, R. Del Bel, J.T. Seki, A. Rafii, W. Xu, G. Koren, N. Shear, M.K. Krzyzanowska, D. Howell, and G. Liu, Managing skin toxicities related to panitumumab. J Am Acad Dermatol, 2014. 71(4): p. 754-9.
125. Azad, A.K., X. Qiu, K. Boyd, Q. Kuang, M. Emami, N. Perera, P. Palepu, D. Patel, Z. Chen, D. Cheng, R. Feld, N.B. Leighl, F.A. Shepherd, M.S. Tsao, W. Xu, G. Liu, and S. Cuffe, A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC). Lung Cancer, 2014. 84(3): p. 289-94.
126. Wang, J.R., S.J. Gramling, D.P. Goldstein, D. Cheng, D. Chen, A.K. Azad, A. Tse, H. Hon, Z. Chen, M. Mirshams, C. Simpson, S.H. Huang, S. Marquez, B. O'Sullivan, F.F. Liu, H. Roberts, W. Xu, D.H. Brown, R.W. Gilbert, P.J. Gullane, J.C. Irish, D.N. Reisman, and G. Liu, Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk. Carcinogenesis, 2013. 34(5): p. 1012-7.
127. Kashigar, A., S. Habbous, L. Eng, B. Irish, E. Bissada, J. Irish, D. Brown, R. Gilbert, P. Gullane, W. Xu, S.H. Huang, I. Witterick, J. Freeman, B. O'Sullivan, J. Waldron, G. Liu, and D. Goldstein, Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patients. Cancer, 2013. 119(15): p. 2701-9.
128. Habbous, S., K.P. Chu, X. Qiu, A. La Delfa, L.T. Harland, E. Fadhel, A. Hui, B. Perez-Ordonez, I. Weinreb, F.F. Liu, J. Waldron, B. O'Sullivan, D. Goldstein, W. Xu, S.H. Huang, and G. Liu, The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre. Cancer Epidemiol, 2013. 37(6): p. 820-9.
129. Habbous, S., K.P. Chu, L.T. Harland, A. La Delfa, E. Fadhel, B. Sun, W. Xu, A. Wong, D. Howell, J. Ringash, J. Waldron, B. O'Sullivan, D. Goldstein, S.H. Huang, and G. Liu, Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patients. Oral Oncol, 2013. 49(5): p. 407-12.
130. Eng, L. and G. Liu, VEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 update. Pharmacogenomics, 2013. 14(13): p. 1659-67.
131. Azad, A.K., I. Bairati, X. Qiu, H. Huang, D. Cheng, G. Liu, F. Meyer, A. Adjei, and W. Xu, Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients. Int J Cancer, 2013. 132(11): p. 2520-7.
132. Renouf, D.J., S. Welch, M.J. Moore, M.K. Krzyzanowska, J. Knox, R. Feld, G. Liu, H. MacKay, J. Petronis, L. Wang, and E. Chen, A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer. Cancer Chemother Pharmacol, 2012. 69(5): p. 1339-44.
133. Liu, G., D. Cheng, K. Ding, A. Le Maitre, N. Liu, D. Patel, Z. Chen, L. Seymour, F.A. Shepherd, and M.S. Tsao, Pharmacogenetic analysis of BR.21, a placebo-controlled randomized phase III clinical trial of erlotinib in advanced non-small cell lung cancer. J Thorac Oncol, 2012. 7(2): p. 316-22.
134. Horgan, A.M., N.B. Leighl, L. Coate, G. Liu, P. Palepu, J.J. Knox, N. Perera, M. Emami, and S.M. Alibhai, Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study. Am J Clin Oncol, 2012. 35(4): p. 322-8.
135. Habbous, S., V. Pang, L. Eng, W. Xu, G. Kurtz, F.F. Liu, H. Mackay, E. Amir, and G. Liu, p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis. Clin Cancer Res, 2012. 18(23): p. 6407-15.
136. Geraci, J., G. Liu, and I. Jurisica, Algorithms for systematic identification of small subgraphs. Methods Mol Biol, 2012. 804: p. 219-44.
137. Fehringer, G., G. Liu, M. Pintilie, J. Sykes, D. Cheng, N. Liu, Z. Chen, L. Seymour, S.D. Der, F.A. Shepherd, M.S. Tsao, and R.J. Hung, Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue. Cancer Epidemiol Biomarkers Prev, 2012. 21(7): p. 1097-104.
138. Eng, L., A.K. Azad, S. Habbous, V. Pang, W. Xu, A.H. Maitland-van der Zee, S. Savas, H.J. Mackay, E. Amir, and G. Liu, Vascular endothelial growth factor pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a systematic review and meta-analysis. Clin Cancer Res, 2012. 18(17): p. 4526-37.
139. Diaz-Padilla, I., E. Amir, S. Marsh, G. Liu, and H. Mackay, Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: a systematic review. Gynecol Oncol, 2012. 124(2): p. 354-65.
140. Cheung, W.Y., R. Zhai, P. Bradbury, J. Hopkins, M.H. Kulke, R.S. Heist, K. Asomaning, C. Ma, W. Xu, Z. Wang, S. Hooshmand, L. Su, D.C. Christiani, and G. Liu, Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma. Int J Cancer, 2012. 131(11): p. 2478-86.
141. Azad, A.K., I. Bairati, E. Samson, D. Cheng, M. Mirshams, X. Qiu, S. Savas, J. Waldron, C. Wang, D. Goldstein, W. Xu, F. Meyer, and G. Liu, Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival. Clin Cancer Res, 2012. 18(1): p. 196-206.
142. Azad, A.K., I. Bairati, E. Samson, D. Cheng, L. Cheng, M. Mirshams, S. Savas, J. Waldron, C. Wang, D. Goldstein, W. Xu, F. Meyer, and G. Liu, Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers. Cancer, 2012. 118(6): p. 1554-65.
143. Ter-Minassian, M., Z. Wang, K. Asomaning, M.C. Wu, C.Y. Liu, J.K. Paulus, G. Liu, P.A. Bradbury, R. Zhai, L. Su, C.S. Frauenhoffer, S.M. Hooshmand, I. De Vivo, X. Lin, D.C. Christiani, and M.H. Kulke, Genetic associations with sporadic neuroendocrine tumor risk. Carcinogenesis, 2011. 32(8): p. 1216-22.
144. Sykes, J., L. Cheng, W. Xu, M.S. Tsao, G. Liu, and M. Pintilie, Addition of multiple rare SNPs to known common variants improves the association between disease and gene in the Genetic Analysis Workshop 17 data. BMC Proc, 2011. 5 Suppl 9: p. S97.
145. Liu, G., S. Gramling, D. Munoz, D. Cheng, A.K. Azad, M. Mirshams, Z. Chen, W. Xu, H. Roberts, F.A. Shepherd, M.S. Tsao, and D. Reisman, Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk. Oncogene, 2011. 30(29): p. 3295-304.
146. Horgan, A.M., B. Yang, A.K. Azad, E. Amir, T. John, D.W. Cescon, P. Wheatley-Price, R.J. Hung, F.A. Shepherd, and G. Liu, Pharmacogenetic and germline prognostic markers of lung cancer. J Thorac Oncol, 2011. 6(2): p. 296-304.
147. Horgan, A.M., J.J. Knox, G. Liu, C. Sahi, P.A. Bradbury, and N.B. Leighl, Capecitabine or infusional 5-fluorouracil for gastroesophageal cancer: a cost-consequence analysis. Curr Oncol, 2011. 18(2): p. e64-70.
148. Coate, L.E., C. Massey, A. Hope, A. Sacher, K. Barrett, A. Pierre, N. Leighl, A. Brade, M. de Perrot, T. Waddell, G. Liu, R. Feld, R. Burkes, B.C. Cho, G. Darling, A. Sun, S. Keshavjee, A. Bezjak, and F.A. Shepherd, Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer. J Thorac Oncol, 2011. 6(3): p. 537-44.
149. Cheng, L., P. Hu, J. Sykes, M. Pintilie, G. Liu, and W. Xu, A pathway-based association analysis model using common and rare variants. BMC Proc, 2011. 5 Suppl 9: p. S85.
150. Wheatley-Price, P., B. Yang, D. Patsios, D. Patel, C. Ma, W. Xu, N. Leighl, R. Feld, B.C. Cho, B. O'Sullivan, H. Roberts, M.S. Tsao, M. Tammemagi, M. Anraku, Z. Chen, M. de Perrot, and G. Liu, Soluble mesothelin-related Peptide and osteopontin as markers of response in malignant mesothelioma. J Clin Oncol, 2010. 28(20): p. 3316-22.
151. Wang, Q., A.H. Wang, H.S. Tan, N.N. Feng, Y.J. Ye, X.Q. Feng, G. Liu, Y.X. Zheng, and Z.L. Xia, Genetic polymorphisms of DNA repair genes and chromosomal damage in workers exposed to 1,3-butadiene. Carcinogenesis, 2010. 31(5): p. 858-63.
152. Liu, G., D.W. Cescon, R. Zhai, W. Zhou, M.H. Kulke, C. Ma, W. Xu, L. Su, K. Asomaning, R.S. Heist, J.C. Wain, T.J. Lynch, and D.C. Christiani, p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma. Dis Esophagus, 2010. 23(1): p. 36-9.
153. Coate, L., S. Cuffe, A. Horgan, R.J. Hung, D. Christiani, and G. Liu, Germline genetic variation, cancer outcome, and pharmacogenetics. J Clin Oncol, 2010. 28(26): p. 4029-37.
154. Chan, K., G. Liu, L. Miller, C. Ma, W. Xu, C.M. Schlachta, and G. Darling, Lack of correlation between a self-administered subjective GERD questionnaire and pathologic GERD diagnosed by 24-h esophageal pH monitoring. J Gastrointest Surg, 2010. 14(3): p. 427-36.
155. Savas, S. and G. Liu, Genetic variations as cancer prognostic markers: review and update. Hum Mutat, 2009. 30(10): p. 1369-77.
156. Savas, S. and G. Liu, Studying genetic variations in cancer prognosis (and risk): a primer for clinicians. Oncologist, 2009. 14(7): p. 657-66.
157. Savas, S., J. Geraci, I. Jurisica, and G. Liu, A comprehensive catalogue of functional genetic variations in the EGFR pathway: protein-protein interaction analysis reveals novel genes and polymorphisms important for cancer research. Int J Cancer, 2009. 125(6): p. 1257-65.
158. Cheung, W.Y., R. Zhai, M.H. Kulke, R.S. Heist, K. Asomaning, C. Ma, Z. Wang, L. Su, M. Lanuti, K.K. Tanabe, D.C. Christiani, and G. Liu, Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk. Carcinogenesis, 2009. 30(8): p. 1363-7.
159. Cheung, W.Y. and G. Liu, Genetic variations in esophageal cancer risk and prognosis. Gastroenterol Clin North Am, 2009. 38(1): p. 75-91, viii.
160. Cescon, D.W., P.A. Bradbury, K. Asomaning, J. Hopkins, R. Zhai, W. Zhou, Z. Wang, M. Kulke, L. Su, C. Ma, W. Xu, A.L. Marshall, R.S. Heist, J.C. Wain, T.J. Lynch, D.C. Christiani, and G. Liu, p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosis. Clin Cancer Res, 2009. 15(9): p. 3103-9.
161. Bradbury, P.A., R. Zhai, C. Ma, W. Xu, J. Hopkins, M.J. Kulke, K. Asomaning, Z. Wang, L. Su, R.S. Heist, T.J. Lynch, J.C. Wain, D. Christiani, and G. Liu, Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis. Clin Cancer Res, 2009. 15(14): p. 4680-5.
162. Bradbury, P.A., R. Zhai, J. Hopkins, M.H. Kulke, R.S. Heist, S. Singh, W. Zhou, C. Ma, W. Xu, K. Asomaning, M. Ter-Minassian, Z. Wang, L. Su, D.C. Christiani, and G. Liu, Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis. Carcinogenesis, 2009. 30(5): p. 793-8.
163. Bradbury, P.A., M.H. Kulke, R.S. Heist, W. Zhou, C. Ma, W. Xu, A.L. Marshall, R. Zhai, S.M. Hooshmand, K. Asomaning, L. Su, F.A. Shepherd, T.J. Lynch, J.C. Wain, D.C. Christiani, and G. Liu, Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes. Pharmacogenet Genomics, 2009. 19(8): p. 613-25.
164. Wheatley-Price, P., K. Asomaning, A. Reid, R. Zhai, L. Su, W. Zhou, A. Zhu, D.P. Ryan, D.C. Christiani, and G. Liu, Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma. Cancer, 2008. 112(5): p. 1037-42.
165. Tse, D., R. Zhai, W. Zhou, R.S. Heist, K. Asomaning, L. Su, T.J. Lynch, J.C. Wain, D.C. Christiani, and G. Liu, Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk. Cancer Causes Control, 2008. 19(10): p. 1077-83.
166. Liu, G., P. Wheatley-Price, W. Zhou, S. Park, R.S. Heist, K. Asomaning, J.C. Wain, T.J. Lynch, L. Su, and D.C. Christiani, Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk. Int J Cancer, 2008. 122(4): p. 915-8.
167. Liu, G., S. Gurubhagavatula, W. Zhou, Z. Wang, B.Y. Yeap, K. Asomaning, L. Su, R. Heist, T.J. Lynch, and D.C. Christiani, Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib. Pharmacogenomics J, 2008. 8(2): p. 129-38.
168. Hopkins, J., D.W. Cescon, D. Tse, P. Bradbury, W. Xu, C. Ma, P. Wheatley-Price, J. Waldron, D. Goldstein, F. Meyer, I. Bairati, and G. Liu, Genetic polymorphisms and head and neck cancer outcomes: a review. Cancer Epidemiol Biomarkers Prev, 2008. 17(3): p. 490-9.
169. Früh, M., W. Zhou, R. Zhai, L. Su, R.S. Heist, J.C. Wain, N.S. Nishioka, T.J. Lynch, F.A. Shepherd, D.C. Christiani, and G. Liu, Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma. Br J Cancer, 2008. 98(4): p. 689-92.
170. Bradbury, P.A., R.S. Heist, M.H. Kulke, W. Zhou, A.L. Marshall, D.P. Miller, L. Su, S. Park, J. Temel, P. Fidias, L. Sequist, T.J. Lynch, J.C. Wain, F.A. Shepherd, D.C. Christiani, and G. Liu, A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies. Cancer Epidemiol Biomarkers Prev, 2008. 17(1): p. 204-11.